These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28727266)

  • 1. Next-generation sequencing of cytologic preparations: An analysis of quality metrics.
    Hwang DH; Garcia EP; Ducar MD; Cibas ES; Sholl LM
    Cancer Cytopathol; 2017 Oct; 125(10):786-794. PubMed ID: 28727266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of next-generation sequencing for the identification of clinically relevant variants in cytology smears in lung adenocarcinoma.
    Baum JE; Zhang P; Hoda RS; Geraghty B; Rennert H; Narula N; Fernandes HD
    Cancer Cytopathol; 2017 Jun; 125(6):398-406. PubMed ID: 28272845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers.
    Ramani NS; Chen H; Broaddus RR; Lazar AJ; Luthra R; Medeiros LJ; Patel KP; Rashid A; Routbort MJ; Stewart J; Tang Z; Bassett R; Manekia J; Barkoh BA; Dang H; Roy-Chowdhuri S
    Cancer Cytopathol; 2021 May; 129(5):374-382. PubMed ID: 33119213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the success of next-generation sequencing in cytology specimens.
    Roy-Chowdhuri S; Goswami RS; Chen H; Patel KP; Routbort MJ; Singh RR; Broaddus RR; Barkoh BA; Manekia J; Yao H; Medeiros LJ; Staerkel G; Luthra R; Stewart J
    Cancer Cytopathol; 2015 Nov; 123(11):659-68. PubMed ID: 26230354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
    Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
    Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung.
    Karnes HE; Duncavage EJ; Bernadt CT
    Cancer Cytopathol; 2014 Feb; 122(2):104-13. PubMed ID: 24227699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance differences between conventional smears and liquid-based preparations of thyroid fine-needle aspiration samples: analysis of 47,076 responses in the College of American Pathologists Interlaboratory Comparison Program in Non-Gynecologic Cytology.
    Fischer AH; Clayton AC; Bentz JS; Wasserman PG; Henry MR; Souers RJ; Moriarty AT
    Arch Pathol Lab Med; 2013 Jan; 137(1):26-31. PubMed ID: 23276172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical next-generation sequencing in patients with non-small cell lung cancer.
    Hagemann IS; Devarakonda S; Lockwood CM; Spencer DH; Guebert K; Bredemeyer AJ; Al-Kateb H; Nguyen TT; Duncavage EJ; Cottrell CE; Kulkarni S; Nagarajan R; Seibert K; Baggstrom M; Waqar SN; Pfeifer JD; Morgensztern D; Govindan R
    Cancer; 2015 Feb; 121(4):631-9. PubMed ID: 25345567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cytocentrifugation supernatant fluid and formalin-fixed paraffin-embedded tissue for targeted next-generation sequencing.
    Janaki N; Harbhajanka A; Michael CW; Bomeisl P; Wasman J; Atchley M; Miskiewicz K; Alouani D; Sadri N
    Cancer Cytopathol; 2019 May; 127(5):297-305. PubMed ID: 30933438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic utility of next-generation sequencing on FNA biopsies of melanocytic uveal lesions.
    Han LM; Khanafshar E; Afshar AR; Calkins SM
    Cancer Cytopathol; 2020 Jul; 128(7):499-505. PubMed ID: 32196967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing in residual liquid-based cytology specimens for cancer genome analysis.
    Yamaguchi T; Akahane T; Harada O; Kato Y; Aimono E; Takei H; Tasaki T; Noguchi H; Nishihara H; Kamata H; Tanimoto A
    Diagn Cytopathol; 2020 Nov; 48(11):965-971. PubMed ID: 32511899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
    Bellevicine C; Sgariglia R; Malapelle U; Vigliar E; Nacchio M; Ciancia G; Eszlinger M; Paschke R; Troncone G
    Cancer Cytopathol; 2016 Nov; 124(11):776-784. PubMed ID: 27717198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platform.
    Morris SM; Subramanian J; Gel ES; Runger GC; Thompson EJ; Mallery DW; Weiss GJ
    PLoS One; 2018; 13(4):e0196556. PubMed ID: 29702695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue.
    Gailey MP; Stence AA; Jensen CS; Ma D
    Cancer Cytopathol; 2015 Jan; 123(1):30-9. PubMed ID: 25186473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.
    Wei S; Lieberman D; Morrissette JJ; Baloch ZW; Roth DB; McGrath C
    Cancer Cytopathol; 2016 May; 124(5):324-9. PubMed ID: 26682952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies.
    Roy-Chowdhuri S; Chen H; Singh RR; Krishnamurthy S; Patel KP; Routbort MJ; Manekia J; Barkoh BA; Yao H; Sabir S; Broaddus RR; Medeiros LJ; Staerkel G; Stewart J; Luthra R
    Mod Pathol; 2017 Apr; 30(4):499-508. PubMed ID: 28084342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor cell block adequacy rate for molecular testing improved with the addition of Diff-Quik-stained smears: Need for better cell block processing.
    Harada S; Agosto-Arroyo E; Levesque JA; Alston E; Janowski KM; Coshatt GM; Eltoum IA
    Cancer Cytopathol; 2015 Aug; 123(8):480-7. PubMed ID: 25955105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Validation of Cytology Specimens for Next-Generation Sequencing and Clinical Practice Experience.
    Balla A; Hampel KJ; Sharma MK; Cottrell CE; Sidiropoulos N
    J Mol Diagn; 2018 Nov; 20(6):812-821. PubMed ID: 29981866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas.
    Khode R; Larsen DA; Culbreath BC; Parrish S; Walker KL; Sayage-Rabie L; Beissner RS; Rao A
    Cancer Cytopathol; 2013 Jul; 121(7):361-9. PubMed ID: 23364874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer adrenal gland metastasis: Optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing.
    Gleeson FC; Kipp BR; Levy MJ; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Lazaridis KN; Kerr SE
    Cancer Cytopathol; 2014 Nov; 122(11):822-32. PubMed ID: 25045116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.